4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-029964
PRESIDENT AND CEO sold 17,500 shares at an average $43.07 ($753,680)
- PRESIDENT AND CEO acquired 75,161 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Option exercise 10b5-1 | +3,772 | $2.90 | $10,927 | 89,714 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Sale 10b5-1 | −3,772 | $41.33 | $155,883 | 85,942 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Option exercise 10b5-1 | +2,195 | $2.90 | $6,358 | 88,137 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Sale 10b5-1 | −2,195 | $42.35 | $92,949 | 85,942 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Option exercise 10b5-1 | +5,023 | $2.90 | $14,551 | 90,965 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Sale 10b5-1 | −5,023 | $43.52 | $218,609 | 85,942 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Option exercise 10b5-1 | +4,635 | $2.90 | $13,427 | 90,577 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Sale 10b5-1 | −4,635 | $44.03 | $204,094 | 85,942 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Option exercise 10b5-1 | +1,875 | $2.90 | $5,432 | 87,817 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Sale 10b5-1 | −1,875 | $43.81 | $82,144 | 85,942 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-19 | Option exercise 10b5-1 | +57,661 | $2.90 | $167,032 | 143,603 | D |
| Derivatives | |||||||
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 686,087 | D | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-18 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 684,212 | D | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-12-19 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −57,661 | 626,551 | D | ||
| Open-market sales · 17,500 sh · avg $43.07 · $753,680 | |||||||
Loading xslF345X05/form4-12202024_091238.xml…